Citadel Advisors »

Arcutis Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $202k 63k 3.23
2023-09-30 $1.5M 287k 5.31
2023-06-30 $1.1M 113k 9.53
2023-03-31 $3.3M 298k 11.00
2022-12-31 $465k 31k 14.80
2022-06-30 $4.5M 210k 21.31
2022-03-31 $4.1M 212k 19.27
2021-12-31 $5.8M 280k 20.74
2021-09-30 $6.8M 286k 23.89
2021-06-30 $13M 466k 27.27
2021-03-31 $13M 453k 28.93
2020-12-31 $3.8M 134k 28.13
2020-09-30 $450k 15k 29.32
2020-06-30 $1000k 33k 30.22
2020-03-31 $1.7M 56k 29.81